Literature DB >> 30884013

Independent prescribing in primary care: A survey of patients', prescribers' and colleagues' perceptions and experiences.

Ali M K Hindi1, Elizabeth M Seston1, Dianne Bell1, Douglas Steinke1, Sarah Willis1, Ellen I Schafheutle1.   

Abstract

Besides doctors and dentists, an increasing range of healthcare professionals, such as nurses, pharmacists and podiatrists, can become independent prescribers (IPs). As part of an evaluation for independent prescribing funded training, this study investigated views and experiences of IPs, their colleagues and patients about independent prescribing within primary care. Questionnaires capturing quantitative and qualitative data were developed for IPs, their colleagues and patients, informed by existing literature and validated instruments. IPs were identified following independent prescribing training funded by Health Education England Northwest in 2015-2017. Quantitative data were analysed using descriptive statistics and qualitative data were analysed thematically. Twenty-four patients, 20 IPs and 26 colleagues responded to the questionnaires. Most patient respondents had a long-term medical condition (n = 17) and had regular medicines prescribed (n = 21). IPs were nurses (n = 14), pharmacists (n = 4), one podiatrist (n = 1) and one was unknown. Half of the IPs were current prescribers (n = 10), the other half were still training (to become) IPs (n = 10). Colleague respondents were doctors and nurses (n = 15) other healthcare professionals (n = 8) and practice managers (n = 3). Both current IPs (n = 9) and colleague respondents (n = 25) (strongly) agreed that independent prescribing improved the quality of care provided for patients. Nearly all colleagues were supportive of independent prescribing and believed that they worked well with IPs (n = 25). Patients' perceptions and experiences of their consultations with the IP were mostly positive with the vast majority of respondents (strongly) agreeing that they were very satisfied with their visit to the IP (n = 23). Key barriers and enablers to independent prescribing were centred on IPs' knowledge, competence and organisational factors such as workload, effective teamwork and support from their colleagues. Findings from this study were mainly positive but indicate a need for policy strategies to tackle longstanding barriers to independent prescribing. However, a larger sample size is needed to confirm findings.
© 2019 John Wiley & Sons Ltd.

Entities:  

Keywords:  colleagues; independent prescribers; independent prescribing; non-medical prescribing; patients; primary care

Mesh:

Year:  2019        PMID: 30884013     DOI: 10.1111/hsc.12746

Source DB:  PubMed          Journal:  Health Soc Care Community        ISSN: 0966-0410


  5 in total

Review 1.  Conceptual aspects, impact, and state of the art of dependent prescription in Brazil: narrative review.

Authors:  Heuler S Andrade; Eliete A A Guimarães; Paulo R Obreli Neto; Mariana L Pereira; Maria O B Zanetti; Tiago M Reis; André O Baldoni
Journal:  Porto Biomed J       Date:  2020-06-04

Review 2.  A decade of independent prescribing in the UK: a review of progress.

Authors:  Matthew Tj Fitzpatrick; Alan M Borthwick
Journal:  J Foot Ankle Res       Date:  2022-05-11       Impact factor: 3.050

3.  Medicines prescribed by non-medical independent prescribers in primary care in Wales: a 10-year longitudinal study April 2011-March 2021.

Authors:  Paul Deslandes; Hannah Blowers; Kath Haines; Karen Hodson; Rhian Deslandes
Journal:  BMJ Open       Date:  2022-02-24       Impact factor: 2.692

4.  "A little bit more looking…listening and feeling" A qualitative interview study exploring advanced clinical practice in primary care and community pharmacy.

Authors:  Elizabeth Mary Seston; Ellen Ingrid Schafheutle; Sarah Caroline Willis
Journal:  Int J Clin Pharm       Date:  2021-11-22

5.  Paramedic independent prescribing: a qualitative study of early adopters in the UK.

Authors:  Karen Stenner; Suzanne van Even; Andy Collen
Journal:  Br Paramed J       Date:  2021-05-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.